Become a member
LyonbioLink
Newsletter
Fr
En
Lyonbiopole
Lyonbiopole missions
The Lyonbiopole team
Governance
Board of Directors
Members of the Board
The technical group, Gtech
Our public funders
Our members and associated members
Press area
Press releases
Communication tools
Mobile app
Become a member
Contact us
Research and innovation
Goals
R&D project support
Setting up and funding a project
Project accreditation
Supporting a European project
Project monitoring
Scientific coordination
Partnering Day
Bluesky Meeting
Workshops and topicaldays
Project funding
Lyonbiopole actions
Calls for projects
Clinical innovation
Structuring program
MabDesign
Upcoming events
Economic development
Goals
Private investment
Private Inv€stments Day
Inv€stor Meetings
Access to skills
GPEC and training initiatives
Intellectual property and consortium agreements
Networking
Lunch Break Partnering
Open Innovation Meetings
Life science directory
Upcoming events
International
Goals
Europe
The support offer to Europe
Main European funding
Our clusters partners
Our European projects
International funding tools
The International Representation and Expertise Programme – IREP
ITPP
Cooperation with the CQDM
Our international trade missions
Upcominig events
Facilities
Our labs offer
Our offices offer
Contact-us
Directories
Companies
Consultants & Service providers
Research units
Healthcare institutions
Collaborative Clinical Research Structures
R&D projects
Diary – News
Upcoming events
All events
Our events
In partnership
Around our themes
News
All news
Lyonbiopole
Our members
Focus on
New members
Blog
Newsletter
Lyonbiopole in action
Diary - News
All news
News
All news
Lyonbiopole
Our members
Focus on
Blog
New member
VALBIOTIS announces a global strategic partnership with NESTLÉ HEALTH SCIENCE
February
6
th
,
2020
for the development and commercialization of TOTUM-63, a plant-derived active substance with clinically demonstrated metabolic health benefits on prediabetics
Cynbiose receives €1.9 million to launch CYNBIOME
January
28
th
,
2020
CYNBIOME receives funding under Investments for the Future Program (PiA), supplemented by €3M ($3.3M) of Cynbiose’s own funds....
Signia Therapeutics, Cynbiose and the VirPath academic laboratory announce the launch of the METABIOSE project
Décember
9
th
,
2019
This R&D project aims to advance the development of innovative therapeutic treatments in the field of respiratory infections.
Laclarée raises 2m€
Décember
9
th
,
2019
Lyon, France. 2019, November 15 th In Europe, more than 25 million presbyopes are unsatisfied with progressive lenses....
Keranova raises €24M in second round of financing
September
10
th
,
2019
Funds will enable company to finalize regulatory process with view to obtaining CE mark for ultra-fast robotized...
IXALTIS announces successful completion of phase 2 for its compound Litoxtine
May
15
th
,
2019
Toulouse (31) /Archamps (74), May, 14th, 2019 – Ixaltis is pleased to announce successful completion of the...
NH TherAguix announces a €13 million round of fundraising, led by Bpifrance
April
15
th
,
2019
Grenoble/Lyon/Paris (France) – 11 April 2019 – NH TherAguix announces the closing of its €13 million...
4 Lyonbiopole’s members laureats of the « Concours d’Innovation »
February
22
th
,
2019
Among the 65 winners of the “Concours d’Innovation”, 4 Lyonbiopole’s members (LXRepair, MagIA Diagnostics, Medimprint and Rheonova)...
MATHYM receives financial support to promote and scale-up its new nano-zirconia
January
9
th
,
2019
Mathym discovered a unique and innovative manufacturing process for transparent zirconia dispersions. First results generated by the R&D team...
CarThera closes €9M ($10.3M) Series B funding round
Décember
13
th
,
2018
Funding will enable company to launch multi-center trial in patients with recurrent glioblastoma and develop clinical pipeline Paris,...
Diabeloop obtains CE marking and launches new round of funding
November
12
th
,
2018
The disruptive innovation for autonomous management of T1D Pari, November 7: Diabeloop announced today it has received the...
ORPHELIA Pharma: Granting of the marketing authorization for Kigabeq®
October
1
st
,
2018
Paris and Lyon, October 1st, 2018 – ORPHELIA Pharma, a French biopharmaceutical company dedicated to the development...
Novadiscovery and Koelis, Lyonbiopole's members, first french tech #healthtech pass award winners in Auvergne-Rhône-Alpes
September
10
th
,
2018
Following their audition by the French Tech #Healthtech Pass selection committee, Novadiscovery and Koelis, two Lyonbiopole member companies, will...
Adocia and Tonghua Dongbao Announce Global Supply Agreements for Insulin Lispro and Insulin Glargine
June
1
st
,
2018
Tonghua Dongbao (THDB) will manufacture and supply insulin glargine and insulin lispro to Adocia worldwide, excluding China These agreements...
ELSALYS BIOTECH ANNOUNCES THE REGISTRATION OF ITS DOCUMENT DE BASE IN THE CONTEXT OF ITS PROPOSED INITIAL PUBLIC OFFERING ON THE PARIS EURONEXT GROWTH® MARKET
April
20
th
,
2018
Lyon, FRANCE, 20 April 2018, ELSALYS BIOTECH, a new player in immuno-oncology, announces the registration of its...
Theranexus
March
15
th
,
2018
Lyonbiopole’s member Therenaxus is located in Lyon, Theranexus is a clinical-stage biopharmaceutical company that emerged from the French...
SUBLIMED obtains the CE mark
February
14
th
,
2018
This major step allows SUBLIMED to commercialize in France, as of now, its medical device actiTENS for the management...
PX’THERAPEUTICS and ADVAXIS to collaborate for the process development of lm based immunotherapies
January
18
th
,
2018
PX’Therapeutics, a CDMO (Contract Development and Manufacturing Organization) has signed an agreement with Advaxis, Inc., a US-based, clinical...
Biom’Up puts his product on the market
Décember
18
th
,
2017
Biom’Up, specialist in surgical hemostasis, announces today that it has received FDA marketing approval for HEMOBLASTTM Bellows, its flagship...
Mathym launches filyxio® a radiopacifying nano-dispersion made from ytterbium trifluoride (YbF3)
November
21
th
,
2017
After three years of development, Mathym has commenced the commercialization of its first innovative nano-dispersion, a best-in-class radiopacifier called filyxio®
Laclarée
October
27
th
,
2017
Laclarée develops electronic eyewear for presbyopia. Based on a patented fluidic technology, Laclarée builds a product for people who...
Great fundraisings for our members in October !
October
24
th
,
2017
October was a favorable month for fundraising in Auvergne-Rhônes-Alpes. Three of our members are part of these beautiful results:...
LXREPAIR secures €1.1 million from seed funds for the development of its diagnostic kits in radiotherapy and chemotherapy
September
7
th
,
2017
Grenoble, Sept 6th 2017 – LXREPAIR, a French company specialized in the development of disruptive technologies for DNA...
ANAQUANT realizes a first fund raising to become the « Nespresso » of the bionalysis
July
28
th
,
2017
ANAQUANT announces a fundraising campaign with Health Angels Rhône-Alpes. These funds will enable ANAQUANT to implement a commercial strategy in order to launch its innovation, READYBEADS, which facilitates and secures bioanalyses pharmaceutical industry .
A major step in the restoration of Gut Microbiota: MaaT Pharma and Biocodex to industrialize FMT & develop an oral formulation
June
13
th
,
2017
Lyon (France), June 8, 2017. Following their investment in MaaT Pharma a year ago, Biocodex is taking a...
Poxel
May
23
th
,
2017
POXEL is biopharmaceutical company focused on the development of innovative drugs to treat metabolic diseases, including type 2 diabetes. It has just presented positive top line Phase 2bdata results for Imeglimin for the treatment of type 2 diabetes in Japan.
Microlight 3D is the winner of the Medi’Nov 2017 Innovation Trophy
April
20
th
,
2017
Le salon a récompensé la technologie d’impression 3D à résolution submicronique de l’entreprise Microlight3D, issue de l’Université Grenoble Alpes.
Synthelis launches a new High Throughput Multigene Expression service
March
21
th
,
2017
Synthelis, a French biotech company, specialized in cell-free production, purification and characterization of difficult-to-express proteins (ion channels, transporters, GPCRs,...
Edelris Announces Research Collaboration Agreement with Pfizer Inc.
February
23
th
,
2017
Edelris is a contract research company, providing services to Life Sciences customers and partners (pharmas, biotechs and academics), committed to...
Nouveal e-health
January
30
th
,
2017
Nouveal e-health is a software editor in connected health and is the editor of e-fitback, the solution for patient...
SYNAPCELL
Décember
20
th
,
2016
The University of Utah has awarded a subcontract to SynapCell as part of the NIH/NINDS Epilepsy Therapy Screening Program (ETSP).
Novasep and Japanese agent AR Brown extend partnership
November
18
th
,
2016
Stronger local representation in growing Japanese biopharma market will improve Novasep’s cap a city to equip and service Japanese clients
PX’Therapeutics and RELIEF THERAPEUTICS announce a strategic collaboration agreement
October
5
th
,
2016
This strategic collaboration agreement concerns the production of atexakin alfa, a low-dose formulation of the recombinant human protein interleukin 6.
Alma Bio Therapeutics
September
29
th
,
2016
Alma is a healthcare company working to help people who suffer from autoimmune diseases, such as Crohn's Disease and Rheumatoid Arthritis.Alma is making preparations for the therapy to be tested in people suffering from Crohn's Disease. A crowfunding campaign is in progress...
Valneva Announces Successful Generation of a Highly-purified Zika Vaccine Candidate
July
11
th
,
2016
Valneva SE (“Valneva” or “the Company”), a leading pure play vaccine company, today announced that it successfully generated a...
SUBLIMED raises more than 700 000 €
June
24
th
,
2016
SUBLIMED raises more than 700 000 € to industrialize its medical device of the pain treatment.
Focus on Alizée Pharma
May
26
th
,
2016
Alizé Pharma II, a company of the Alizé Pharma Group, acquired by Jazz Pharmaceuticals.
Keranova raises €4m
April
12
th
,
2016
Keranova raises €4m ($4.55 m) in series A funding. Investment will finance development of prototypes for new ophthalmic surgery equipment and launch of a preclinical study.
DIABELOOP
February
29
th
,
2016
DIABELOOP
ENYO Pharma announces closing of a €22 million funding round
February
10
th
,
2016
ENYO Pharma announces closing of a €22 million funding round
Innate Pharma in-licenses Orega Biotech's first-in-class anti-CD39 checkpoint inhibitor program
January
11
th
,
2016
Innate Pharma in-licenses Orega Biotech's first-in-class anti-CD39 checkpoint inhibitor program
AAA Reports 37% growth in sales for the 3th quarter of 2015
Décember
14
th
,
2015
With the announcement of positive Phase 3 results from the NETTER-1 trial, and the subsequent completion of a successful initial public offering in November, AAA believes to be well positioned to advance the development of our lead drug candidate Lutathera in patients with advanced midgut neuroendocrine tumors.
ElsaLys Biotech raising 2,7 M€
November
3
th
,
2015
ElsaLys Biotech lève 2,7 millions d'euros
EVEON sign a new industrial partnership
October
9
th
,
2015
EVEON, designer and manufacturer of medical devices for the preparation and/or administration of medicines, announces the signing of a...
Pragma Therapeutics
July
29
th
,
2015
Pragma Therapeutics has the French status of “Young innovative Company”, and joined the incubator Pulsalys based in Lyon last...
PDC*line Pharma receives ATMP classification
June
23
th
,
2015
PDC*line Pharma receives Advanced-Therapy Medicinal Product (ATMP)classification from the European Medicines Agency (EMA) for its new class oftherapeutic cancer...
Focus on Kallistem
April
27
th
,
2015
Kallistem is a Lyonbiopole member company which started its 1st fundraiser via Wiseed, a crowdfunding platform for the financing...
Focus on Alizé Pharma
March
26
th
,
2015
Alizé Pharma, a company member of Lyonbiopole,announces that it has raised €1.8 million (USD $1.94 million) in a first financing...
Focus on Fab’entech
February
20
th
,
2015
Fab’entech , innovative biopharmaceutical company member of Lyonbiopole is specialized since five years already , in the Treatment of Emerging Infectious...
Focus on ImmunID
January
23
th
,
2015
ImmunID Announces Rapid Enrolment of Patients in its PREDICT-ID Melanoma Clinical Trial for Prediction of Response to an Immunotherapy...
Focus on Alizé Pharma
Décember
15
th
,
2014
Alizé Pharma is a company member of Lyonbiopole, specialized in the development of biopharmaceuticals for the treatment of metabolic...
Focus on Theranexus
November
21
th
,
2014
Theranexus is a biotechnology company spun off from CEA and member of Lyonbiopole. She has just completed a fundraising...
Focus on Erytech Pharma
October
29
th
,
2014
Zoom sur Erytech Pharma
Focus on Genel
September
30
th
,
2014
On July 3rd, 2014 , the start-up project Genel, hosted at the Grenoble business incubator GRAIN was created successfully....
Focus on Fluoptics
June
24
th
,
2014
Fluoptics, Lyonbiopole member’s, based in Grenoble, develops and markets innovative solutions in the field of fluorescence image-guided surgery. Early...
Focus on Cellipse
May
28
th
,
2014
Presentation Cellipse is a company member of Lyonbiopole based in Grenoble. It was created in early 2013 by three...